Steven E. Lufkin
Chief Executive Officer at SeLux Diagnostics, Inc.
Steven E. Lufkin active positions
| Companies | Position | Start | End |
|---|---|---|---|
SeLux Diagnostics, Inc.
 SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Director/Board Member | - | - |
| Chief Executive Officer | 2016-12-31 | - |
Career history of Steven E. Lufkin
Former positions of Steven E. Lufkin
| Companies | Position | Start | End |
|---|---|---|---|
| ERBA DIAGNOSTICS, INC. | Corporate Officer/Principal | 2010-05-26 | 2010-09-29 |
Statistics
International
| United States | 3 |
Operational
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
ERBA Diagnostics, Inc.
 ERBA Diagnostics, Inc. Medical SpecialtiesHealth Technology ERBA Diagnostics, Inc. was engaged in manufacturing and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes, and infectious diseases. The company was founded on March 14, 2001 and was headquartered in Miami Lakes, FL. | Health Technology |
SeLux Diagnostics, Inc.
SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Health Technology |
- Stock Market
- Insiders
- Steven E. Lufkin
- Experience
